to further evaluate the efficacy of oral vitamin e in preventing the development of severe retrolental fibroplasia ( rlf ) in very low-birth-weight infants , 100 infants treated with 100 mg/kg/d of vitamin e ( dl-alpha-tocopheryl acetate ) were compared with 75 infants treated with 5 mg/kg/d of vitamin e ( dl-alpha-tocopherol ) in the same nursery during the previous year .
C0994472
dl-alpha-tocopheryl acetate
C0042874
vitamin e